Depression and anxiety in individuals with amyotrophic lateral sclerosis: Epidemiology and management

CNS Drugs

Volumn 21, Issue 4, 2007, Pages 279-291

  Kurt, Anja ^a   Nijboer, Femke ^b   Matuz, Tamara ^b   Kübler, Andrea ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANXIOLYTIC AGENT; BUSPIRONE; DIAZEPAM; FLUOXETINE; LORAZEPAM; OPIATE; PAROXETINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; COGNITIVE THERAPY; CONSTIPATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYMPTOMATOLOGY; UNSPECIFIED SIDE EFFECT;

AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY; DEPRESSION; HUMANS; MALE; MIDDLE AGED;

EID: 34247096470     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200721040-00003     Document Type: Review

References (58)

1. Masur H, Schulte-Oversohl U, Papke K, et al. Sympathetic skin response in patients with amyotrophic lateral sclerosis. Funct Neurol 1995 May-Jun; 10 (3): 131-5
2. Strong MJ, Grace GM, Orange JB, et al. A prospective study of cognitive impairment in ALS. Neurology 1999 Nov 10; 53 (8): 1665-70
3. Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, et al. Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis: a longitudinal study in 52 patients. J Neurol 2005; 252 (7): 772-81
4. Hillemacher T, Grassel E, Tigges S, et al. Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004 Dec; 5 (4): 245-9
5. Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neurone disease. J Neurol Sci 1998 Oct; 160 Suppl. 1: S53-6
6. Rabkin JG, Albert SM, Del Bene ML, et al. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 2005 Jul 12; 65 (1): 62-7
7. Badger TA, Collins-Joyce P. Depression, psychosocial resources, and functional ability in older adults. Clin Nurs Res 2000 Aug; 9 (3): 238-55; discussion 256-9
8. McDonald ER, Wiedenfeld SA, Hillel A, et al. Survival in amyotrophic lateral sclerosis: the role of psychological factors. Arch Neurol 1994 Jan; 51 (1): 17-23
9. Paillisse C, Lacomblez L, Dib M, et al. Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph Lateral Scler Other Motor Neuron Disord 2005 Mar; 6 (1): 37-44
10. Narrow WE, Rae DS, Robins LN, et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002 Feb; 59 (2): 115-23
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994
12. Barraclough J. ABC of palliative care: depression, anxiety, and confusion. BMJ 1997 Nov 22; 315 (7119): 1365-8
13. Rabkin JG, Albert SM, Tider T, et al. Predictors and course of elective long-term mechanical ventilation: a prospective study of ALS patients. Amyotroph Lateral Scler 2006 Jun; 7 (2): 86-95
14. Simmons Z, Bremer BA, Robbins RA, et al. Quality of life in ALS depends on factors other than strength and physical function. Neurology 2000 Aug 8; 55 (3): 388-92
15. Robbins RA, Simmons Z, Bremer BA, et al. Quality of life in ALS is maintained as physical function declines. Neurology 2001 Feb 27; 56 (4): 442-4
16. Kübler A, Winter S, Ludolph AC, et al. Severity of depressive symptoms and quality of life in patients with amyotrophic lateral sclerosis. Neurorehabil Neural Repair 2005 Sep; 19 (3): 182-93
17. Chio A, Gauthier A, Montuschi A, et al. A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry 2004 Nov; 75 (11): 1597-601
18. Albert SM, Rabkin JG, Del Bene ML, et al. Wish to die in end stage ALS. Neurology 2005 Jul 12; 65 (1): 68-74
19. Borasio GD, Sloan R, Pongratz DE. Breaking the news in amyotrophic lateral sclerosis. J Neurol Sci 1998 Oct; 160 Suppl. 1: S127-33
20. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961 Jun; 4: 561-71
21. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965 Jan; 12: 63-70
22. Rabkin JG, Wagner GJ, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 2000 Mar-Apr; 62 (2): 271-9
23. Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology 1999 Apr 22; 52 (7): 1434-40
24. Feinstein A, Feinstein K. Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Disord 2001 Oct; 66 (2-3): 193-8
25. Galeazzi GM, Ferrari S, Giaroli G, et al. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 2005 Oct; 26 (4): 255-62
26. Bungener C, Piquard A, Pradat PF, et al. Psychopathology in amyotrophic lateral sclerosis: a preliminary study with 27 ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2005 Dec; 6 (4): 221-5
27. Houpt JL, Gould BS, Norris Jr FH. Psychological characteristics of patients with amyotrophic lateral sclerosis (ALS). Psychosom Med 1977 Sep-Oct; 39 (5): 299-303
28. Massman PJ, Sims J, Cooke N, et al. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996 Nov; 61 (5): 450-5
29. Tedman BM, Young CA, Williams IR. Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci 1997 Oct; 152 Suppl. 1: S75-9
30. Trail M, Nelson ND, Van JN, et al. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 2003 May 15; 209 (1-2): 79-85
31. Moore SR, Gresham LS, Bromberg MB, et al. A self report measure of affective lability. J Neurol Neurosurg Psychiatry 1997 Jul; 63 (1): 89-93
32. Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neurone disease. Psychol Med 1994 Aug; 24 (3): 625-32
33. Lou JS, Reeves A, Benice T, et al. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003 Jan 14; 60 (1): 122-3
34. Böcker FM, Seibold I, Neundorfer B. Behinderung im Alltag und subjektives Befinden bei Patienten mit fortgeschrittener myatrophisoher Lateralsklerose (ALS). Fortschr Neurol Psychiat 1990; 58: 224-36
35. Kübler A, Winter S, Kaiser J, et al. A questionnaire to measure depression in degenerative neurological diseases [in German]. Z Klin Psychol Psychother 2005; 31 (1): 19-26
36. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 Jun; 67 (6): 361-70
37. Neudert C, Oliver D, Wasner M, et al. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 2001 Jul; 248 (7): 612-6
38. Ganzini L, Johnston WS, Silveira MJ. The final month of life in patients with ALS. Neurology 2002 Aug 13; 59 (3): 428-31
39. Howard RS, Orrell RW. Management of motor neurone disease. Postgrad Med J 2002 Dec; 78 (926): 736-41
40. Andersen PM, Borasio GD, Dengler R, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005 Dec; 12 (12): 921-38
41. Simmons Z. Management strategies for patients with amyotrophic lateral sclerosis from diagnosis through death. Neurologist 2005 Sep; 11 (5): 257-70
42. Forshew DA, Bromberg MB. A survey of clinicians' practice in the symptomatic treatment of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003 Dec; 4 (4): 258-63
43. Amitryptyline in amyotrophic lateral sclerosis [letter]. N Engl J Med 1985 Dec; 313 (23): 1478-9
44. Bradley WG, Anderson F, Bromberg M, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology 2001 Aug 14; 57 (3): 500-4
45. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Muscle Nerve 1999 Aug; 22 (8): 1104-18
46. Chesney MA, Chambers DB, Taylor JM, et al. Coping effectiveness training for men living with HIV: results from a randomized clinical trial testing a group-based intervention. Psychosom Med 2003 Nov-Dec; 65 (6): 1038-46
47. King C, Kennedy P. Coping effectiveness training for people with spinal cord injury: preliminary results of a controlled trial. Br J Clin Psychol 1999 Mar; 38 (Pt 1): 5-14
48. Hecht M, Hillemacher T, Grasel E, et al. Subjective experience and coping in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2002 Dec; 3 (4): 225-31
49. Traynor BJ, Alexander M, Corr B, et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study 1996-2000. J Neurol Neurosurg Psychiatry 2003; 74: 1258-61
50. Van den Berg JP, Kalmin S, Lindeman E, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurol 2005; 65: 1264-7
51. Buchardi N, Rauprich O, Vollmann J. Patienten Selbstbestimmung und Patientenverfügungen aus der Sicht von Patienten mit amyotropher Lateralsklerose: eine qualitative empirische Studie. Ethik der Medizin 2004; 15: 7-21
52. Sullivan MD. Treatment of depression at the end of life: clinical and ethical issues. Semin Clin Neuropsychiatry 1998 Apr; 3 (2): 151-6
53. Hautzinger M, Welz S. Cognitive behavioral therapy for depressed older outpatients: a controlled, randomized trial [in German]. Z Gerontol Geriatr 2004 Dec; 37 (6): 427-35
54. Kennedy P, Duff J, Evans M, et al. Coping effectiveness training reduces depression and anxiety following traumatic spinal cord injuries. Br J Clin Psychol 2003 Mar; 42 (Pt 1): 41-52
55. Young JM, McNicoll P. Against all odds: positive life experiences of people with advanced amyotrophic lateral sclerosis. Health Soc Work 1998 Feb; 23 (1): 35-43
56. Kübler A, Kotchoubey B, Kaiser J, et al. Brain-computer communication: unlocking the locked in. Psychol Bull 2001 May; 127 (3): 358-75
57. Kanfer FH, Saslow G. Behavioral analysis: an alternative to diagnostic classification. Arch Gen Psychiatry 1965 Jun; 12: 529-38
58. Chochinov HM, Wilson KG, Enns M, et al. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry 1997 May; 154 (5): 674-6